China Resources North Medicine assets Reorganization Official road (figure)

Zhang Zhangchun/Map China Resources Pharmaceutical Group and the North Pharmaceutical group formally opened up the second largest pharmaceutical group of the domestic asset consolidation curtain. According to China Resources under the Donga Donkey-hide Gelatin (000423), CR 39 (000999) and the North Medicine under the Wandong Medical (600055), double crane Pharmaceutical (600062) announced today, the China Resources Pharmaceutical Group and the North pharmaceutical group of pharmaceutical assets will be incorporated into a joint venture,　　Beijing state-owned Capital Management Center and China Resources Group will jointly directly/indirectly hold the full equity of the JV company. July 30, the above 4 listed companies have received notice of their own controlling shareholders, Beijing state-owned Capital Management Center, China Resources Co., China Resources (Group) Co., Ltd., China Resources Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical Holdings Limited and Beijing Pharmaceutical Group Co., Ltd. on July 30, 2010, officially signed the The reorganization agreement of Beijing Pharmaceutical Group Limited liability company and China Resources Pharmaceutical Group Co., Ltd.　　The above parties intend to restructure the pharmaceutical assets of China Resources Pharmaceutical Group and North Pharmaceutical group. According to the reorganization agreement, China Resources Group includes all the pharmaceutical assets and business owned by Huarun, including the 50% stake in the North Medicine group owned by China Resources, China Resources Pharmaceutical Group, China Resources Medicine Holdings and its affiliated enterprises, That is, China Resources Medicine holdings of China Resources 39 all 63.59% of the shares and China Resources Medicine control of Donga donkey-gelatin 23.14% of the shares.　　All pharmaceutical assets owned by the North Pharmaceutical group will also be included in the integration, including the North Pharmaceutical group holding 49.12% shares in the company, Wandong Medical 51.51%. It is reported that the "reorganization agreement" is the China Resources Group and the Beijing Municipal People's government signed on April 2, 2010, "on the joint development of pharmaceutical industry and microelectronics industry strategic cooperation Framework Agreement" further implementation.　　After the signing of the reorganization agreement, the parties concerned will jointly actively study and promote the reorganization of the stock rights of the North Pharmaceutical group and China Resources Pharmaceutical group, and implement the reorganization steps as determined by the follow-up consultations between the two parties. Analysis of the industry, China Resources Group Strategic Restructuring of the North Medicine, will help the Chinese resources group to expand resources in the national market scale, will be with the Chinese medicine group, the new pharmaceutical group to form a medical enterprise "tripod" situation. After the completion of the reorganization, China Resources and the North Medicine group in the new pharmaceutical groups in asset size, sales and other aspects will exceed the medicine group, after the group, become the second largest pharmaceutical group.